Anecdotal evidence, recently supported by scientific evidence, suggests that altitude training may offer advantages over sea-level (SL) training [1] [2] [3] [4] [5] . As a consequence, many elite athletes, female as well as male, now train at high altitude in an effort to enhance their SL performance. It is known that the menstrual cycle modulates thermoregulatory and cardiorespiratory responses, both at rest and during exercise, but it is not yet clear how this modulation is altered by moving to a higher altitude (Յ3,000 m), either acutely or chronically.
ing exercise, like VE, would be expected to be higher than in the follicular phase. However, most studies have reported no significant difference in maximal or submaximal exercise VO 2 between these two phases [10, 17, [20] [21] [22] [23] [24] [25] [26] [27] , although one study did find a difference [18] . It should be clear from the above that the presence of a modulating effect of the menstrual cycle on respiratory and metabolic responses to exercise at sea level, and still less its nature, has not yet been demonstrated.
During exposure to acute hypobaric hypoxia (HH), ventilation is enhanced both at rest and during dynamic exercise as compensation for the effects of the decrease in the inspiratory O 2 content [28] . Conceivably, these effects of HH might alter the menstrual cycle-induced modulation of the cardiorespiratory response to exercise. However, it is not known whether this is indeed the case. In fact, very few studies have dealt with this issue, although Beidleman et al. [19] found that VE during dynamic exercise performed either at sea level or during acute exposure to a simulated 4,300 m altitude was no greater in the luteal phase than in the follicular phase, and that neither maximal nor submaximal exercise performance was affected by the phase of the menstrual cycle at either of these altitude levels. In general, the effects of HH on ventilatory response to exercise are known to depend on the altitude, and most athletic training is now conducted at below 3,000 m. For female athletes who usually reside at sea level, information about such modulations would help both in the planning of their training program and in the assessment of their performance when they train at high altitude. Although the significant effects of altitude training per se may derive from longtime acclimation to altitude, an obvious first step in elucidating the effects of the menstrual cycle at altitude seemed to be to study the effects of acute altitude exposure. This being so, when we set out to examine the possible menstrual cycle-induced modulation of the cardiorespiratory response to exercise, and the hypothesis that it might be different between sea level and altitude, we studied acute altitude exposure and chose a simulation level of 3,000 m.
METHODS
Volunteer subjects. Ten moderately trained female athletes volunteered for this study. One of them completed the study, but was eliminated from any further analysis because of inadequate menstrualcycle documentation; so we are actually reporting nine subjects. All subjects were nonsmokers, had no history of cardiopulmonary disease, and were taking no medication. Their mean age, height, initial body weight, and %body fat were 20.2Ϯ1.7 years, 161.2Ϯ 3.6 cm, 54.4Ϯ4.3 kg, and 25.3Ϯ3.2%, respectively. Each of them had a menstrual cycle of 25-32 d, and none had taken oral contraceptives or hormone therapy for at least 1 year before entering the study. None were pregnant, and none had ever been pregnant. Hemoglobin values were normal (12.4Ϯ0.7 g/dl).
All volunteers were lifelong residents at low altitude, and none had had any exposure to altitudes Ͼ1,000 m for at least 1 year before the study. They had all engaged in tennis 5-7 d/week for 2-5 h/d for at least 12 months prior to the study. This study was approved by the Human Subjects Committee of the University of Tsukuba, and each subject gave written informed consent.
Menstrual-cycle documentation. Supportive evidence for normal ovulatory cycles was initially obtained by use of a menstrual cycle-history questionnaire. At the time of enrollment, all subjects were considered to be eumenorrheic (11-14 cycles/year) on the basis of their previous 1 year menstrual-cycle histories. Confirmation of menstrual status during the study was obtained through analysis of daily basal body-temperature charts, and serum estradiol and progesterone levels. A serum progesterone less than 5 ng/ml was accepted as confirmation of the luteal phase [29] .
Study protocol. The study used a balanced experimental design in which each volunteer's ovarian hormones, ventilatory parameters, and exercise performance were evaluated at SL and during HH in both the follicular (approximately 6-12 d after the onset of the menses) and the luteal (5-10 d after the day of ovulation) phases of the menstrual cycle. The four test conditions were: (1) sea level, follicular (SL/F); (2) sea level, luteal (SL/L); (3) acute altitude, follicular (HH/F); and (4) acute altitude, luteal (HH/L). In each session, peak O 2 uptake (VO 2 peak ) and ventilatory threshold (T vent ) were measured [30] . All exercise tests were performed at the same time on each day. To minimize training and/or order effects, the four test conditions (SL/F, SL/L, HH/F, and HH/L) were randomized. A given subject took part in only one session on a given day, and in two sessions (SL and HH) in a given menstrual phase with an interval of 1 d.
Environmental conditions. Each exercise test was performed in a hypobaric chamber maintained at a temperature of 20Ϯ1°C, a relative humidity of 60Ϯ 10%, and at ambient O 2 and CO 2 concentrations of 20.9 and 0.03%, respectively. At 1 week before the first test, each volunteer entered the chamber in order to familiarize herself with the experimental condi-tions: at this time, the chamber was decompressed to the barometric equivalent of 3,000 m for 20 min. For the exercise test under the HH condition, the chamber was gradually decompressed to the barometric equivalent of 3,000 m (526 mmHg). The time required for decompression was 20 min. The exercise test, which was started at 10 min after decompression had been completed, took approximately 15 min. Before the exercise test at SL, to keep the subjects unaware of the environmental conditions, the chamber was gradually decompressed to the barometric equivalent of 1,000 m (674 mmHg) over a period of 10 min, and then gradually returned to SL over a period of 10 min. For each test, three test-conductors and one subject entered the chamber.
Ovarian-hormone analysis. Ovarian-hormone levels were measured to enable us to document the phase of the menstrual cycle. A resting blood sample was obtained from a large antecubital vein before each exercise test for measurement of estradiol and progesterone levels. A serum progesterone value Ͼ5 ng/ml was accepted as confirmation of the mid-luteal phase [29] . The serum concentrations of estradiol and progesterone were determined in duplicate by means of a solid-phase 125 I radioimmunoassay (Diagnostic Products Corporation, Los Angeles, CA, USA). The limit of detection was 8 pg/ml for serum estradiol and 0.02 ng/ml for serum progesterone. The intraassay coefficients of variation were less than 10%.
Peak-exercise test. Before each peak-exercise test, the subjects were asked to abstain from alcohol and caffeine for at least 24 h, and to refrain from exercising on the day of the test. Exercise such as high-intensity tennis might lead to exhaustion, and was not permitted in the last 2 d before testing. The subject came to the laboratory more than 1 h after awakening following overnight fasting. We then took anthropometric measurements, and a blood sample was drawn at rest. Before each exercise test, the subject was weighed (wearing only T-shirt and shorts) to the nearest 0.1 kg, and her body composition (% body fat) was measured using a bioimpedance system (HBF-300; Omron, Tokyo, Japan). After a 10 min rest, a resting gas sample was obtained via a sampling mask after the subject had been sitting on a chair for 3 min. Respiratory gases in each breath were measured continuously during the peak-exercise test using a respiromonitor (RM300i; Minato, Osaka, Japan) and a medical gas analyzer (MGA-1100; Perkins Elmer, Milwaukee, USA), which were calibrated using certified gases and a volume standard. VE (BTPS) was measured using a hot-wire flowmeter, and VO 2 (STPD) and carbon dioxide output (VCO 2 , STPD)
were measured for alternate minutes throughout the period of exercise with the aid of a computerized system. VO 2 peak was determined by means of a progressive work-exercise test protocol (using 90 kpm/min (60 rpm) increments up to maximal effort). During exercise, heart rate (HR) was recorded using a HR monitor (PE300; Polar, Kempele, Norway). Maximal effort was indicated by the exercise continuing to exhaustion, and the time to exhaustion was measured. VO 2 peak was taken as the plateau value achieved following an increase in workload. End-tidal O 2 and CO 2 concentrations (FET O 2 , FET CO 2 ) and respiratory exchange ratio (RER) were monitored at the mouth with the aid of a mass spectrometer. Exercise data were tabulated for each of the gas collection periods. Gas exchange parameters (VO 2 , VE, and VCO 2 ) were used as follows to estimate T vent [30] . Break-points in the VCO 2 -VO 2 and VE-VO 2 curves, representing a switch to non-linear increases in VCO 2 and VE relative to VO 2 , were detected visually and used to locate the T vent . The T vent values obtained from these two curves were not significantly different (pϾ0.05), and so they were averaged for further analysis. The ventilatory equivalents for O 2 and CO 2 were expressed as VE/VO 2 and VE/VCO 2 , respectively. The O 2 pulse was expressed as VO 2 /HR. Values for the rating of perceived exertion (RPE) were obtained at rest and during exercise using the whole-body Borg scale [31] . Partial pressures of end-tidal O 2 and CO 2 (PET O 2 , PET CO 2 ) were calculated from FET O 2 and FET CO 2 , respectively, and the barometric pressure measured on the day of the experimental session.
Statistical analysis. All data are presented as meansϮSD. Differences between testing conditions (altitude) as well as differences between follicular and luteal phases were assessed using a multiple-comparison one-way analysis of variance (ANOVA) for repeated measures, with significance set at pϽ0.05. Scheffe's post hoc comparisons were used to identify significant differences among means.
RESULTS

Estradiol and progesterone levels
Among subjects in the follicular phase, resting estradiol levels were within the range 6 to 192 pg/ml, and progesterone levels were 0.5 to 1.8 ng/ml. Among subjects in the luteal phase, the corresponding values were 74 to 236 pg/ml and 5 to 16 ng/ml. Mean resting estradiol and progesterone levels (Table 1) were within previously reported normal ranges for eumenorrheic women [29] .
Rest
The cardiopulmonary data collected at rest are presented in Table 2 and Fig. 1 . There were no significant differences between menstrual-cycle phases or between altitude levels in RPE, RER, tidal volume (VT), respiratory rate, VE, VO 2 , VCO 2 , VE/VCO 2 , PET CO 2 , or VO 2 /HR. Although there was no altitude-difference in VE/VO 2 , it was higher by 19% in SL/L than in SL/F, and higher by 17% in HH/L than in HH/F (Fig. 1) . HR was significantly higher at HH than at SL in the follicular phase, but not in the luteal phase.
Exercise
Cardiopulmonary parameters collected at T vent and at peak-exercise are presented in Table 2 and Fig. 1 .
Submaximal data (at T vent )
At T vent : (1) VO 2 was not affected by menstrualcycle phase (it was ϳ20% lower at HH than at SL in each phase); (2) VE was affected by neither menstrualcycle phase nor altitude; (3) VE/VO 2 was unaffected by menstrual-cycle phase at both altitudes nor by altitude in either phase (Fig. 1a) ; (4) at altitude, VE/VCO 2 was greater in the luteal phase; (5) PET CO 2 was lower by ϳ13% at HH than at SL (in both phases), and showed a menstrual-cycle phase difference only during HH (Fig. 1b) , its value being 8% lower in HH/L than in HH/F (pϽ0.05); (6) VO 2 /HR was not affected by menstual-cycle phase, HH decreased it only in the follicular phase; and (7) there were no phase or altitude differences in RER, VT, respiratory rate, VCO 2 , or HR.
Peak data (at exhaustion)
Neither menstrual-cycle phase nor altitude affected the exercise time to exhaustion (Table 1) . At peak: (1) there was no phase difference in VO 2 at either altitude, but in each phase it was lower by ϳ18% at HH than at SL; (2) VE was not affected by menstrual-cycle phase or altitude; (3) during HH, VE/VO 2 was ϳ35% greater than at SL in each phase, and showed a phase difference only during HH, the value being 27% higher in HH/L than in HH/F (Fig. 1a) ; (4) HR was unaffected by phase or altitude; (5) VO 2 /HR was ϳ22.3% lower at HH than at SL; (6) PET CO 2 was lower at HH than at SL in both phases, and it showed a phase difference only during HH, the HH/L value being 8% lower than , between F and L at the same altitude equivalent. the HH/F value (Fig. 1b) .
DISCUSSION
In this study, we measured the cardiorespiratory responses to cycle exercise up to maximal levels during the follicular and luteal phases of the menstrual cycle, both at sea level and under moderate HH conditions (equivalent of 3,000 m). Our principal finding was that, although at rest or during exercise neither VE or VO 2 in the luteal phase was significantly different between SL and HH, the VE/VO 2 values obtained at rest or during peak exercise at HH were significantly greater in the luteal than in the follicular phase. In addition, we found that the PET CO 2 values obtained during exercise (at T vent or peak) in either luteal or follicular phase were lower at HH than at SL. These findings seem to suggest that modulation of the ventilatory response to exercise occurs due to the menstrual cycle, and is altered when the subject moves to moderate HH conditions.
Under moderate HH conditions (simulation of 3,000 m) in both menstrual phases, VO 2 peak was decreased by ϳ18% compared to the value at SL. Recently, Beidleman et al. [19] reported that at a simulated 4,300 m altitude, VO 2 peak was ϳ27% lower than SL in both phases (luteal and follicular). The above data are consistent with those in previous reports showing that the reduction in VO 2 peak is dependent on the altitude [1, 2, 32] . Most studies have reported that differences in VO 2 during maximal or submaximal exercise were not significant between the luteal and follicular phases at SL [10, 17, [20] [21] [22] [23] [24] [25] [26] [27] , but one study has found such a difference [18] . For instance, it has been reported that: (1) cycle-ergometer performance at an intensity of 60-70% VO 2 peak or less is associated with no significant difference in VO 2 between the luteal and follicular phases [25] ; (2) performance of high-intensity (90% VO 2 peak ) exercise is enhanced in the luteal phase as opposed to the follicular phase [26] ; but (3) there is no difference between these phases when the performance of high-intensity treadmill exercise (90% VO 2 peak ) is examined [23] . As far as altitude is concerned, both Beidleman et al. [19] (at 4,300 m) and our report (at 3,000 m) found that VO 2 peak was not affected by the phase of the menstrual cycle. Since VO 2 peak is generally taken to be an indicator of aerobic work capacity, the above results would seem to suggest that, in trained women, the phase of the menstrual cycle has little or no influence over aerobic work capacity at moderate altitude (e.g., 3,000 m, 4,300 m).
At SL, VE tended to be higher in the luteal phase than in the follicular phase both at rest and during exercise, but the differences were not significant. Given the stimulatory effects of progesterone on resting VE [7, 10, 13, 14, 16, 33, 34] , the VE during exercise would be expected to be higher in the luteal phase than in the follicular phase. However, although the results of several studies on maximal or submaximal exercise support this supposition [8, 10, 17, 26] , some studies have found no difference [19, [21] [22] [23] [24] . In most studies, including the present one, progesterone levels and exercise parameters were measured just one time in each phase of the menstrual cycle, and it is possible that we missed the highest progesterone level in the luteal phase. In fact, a few years ago Williams and Krahenbuhl [18] showed an increased exercise VE at both 55 and 80% VO 2 peak in the mid-luteal phase when progesterone was at the highest level in the entire luteal phase. We cannot tell whether the progesterone levels were at their peak for the luteal phase at the time we made our measurements, but at least we can say that: (1) we detected a significant difference in progesterone level between the luteal and follicular phases, and (2) the mean values we obtained for progesterone and estradiol were within the ranges quoted in previous reports. Taking all this together leads us to postulate that, at SL, VE tends to be higher in the luteal phase than in the follicular phase both at rest and during dynamic exercise, but the data may be affected by individual differences (e.g., in the time at which progesterone peaks during the luteal phase).
In the present study, VE values at maximal exercise level and T vent were unaffected by the phase of the menstrual cycle at the 3,000 m altitude. Beidleman et al. [19] reported similar findings, except that their chosen altitude level was 4,300 m. In our study, VO 2 peak was decreased by altitude, and as a consequence VE/VO 2 and VE/VCO 2 were both greater at HH than at SL in each menstrual phase. Beidleman et al. [19] reported increases of ϳ35 and 22.3% in the peak-exercise values of VE/VO 2 and VE/VCO 2 , respectively, at 4,300 m altitude (as compared to SL). It is widely known that hypoxic stimulation increases VE. The increase in VE/VO 2 seen during peak exercise in our HH groups is in accord with this. Although Beidleman et al. [19] did not show menstrual-cycle phase differences in VE/VO 2 and VE/VCO 2 at peak levels of exercise, in the present study we noted that the VE/ VO 2 and VE/VCO 2 values recorded during peak exercise were greater in the luteal than in the follicular phase during HH. The lower PET CO 2 seen in the luteal phase as compared to the follicular phase during peak exercise at HH indicates that a hyperventilatory response occurred during peak exercise in the luteal phase. Although there are methodological differences between the study by Beidleman et al. [19] and the present one [(1) subjects (active vs. regularly trained, 33 years old vs. 20 years old, respectively), (2) type of exercise test (treadmill vs. bicycle ergometer), and (3) altitude (4,300 m vs. 3,000 m)], the reasons for the discrepancies in the VE/VO 2 and VE/VCO 2 results are unclear. The very presence of a modulating effect of the menstrual cycle on the respiratory and metabolic responses to exercise at SL has previously resisted a possible demonstration [10, 13, 14, [17] [18] [19] [20] [21] [22] [23] , and there may be large individual differences in the respiratory effects of the menstrual cycle at altitude. As far as we know, the only studies on the effects of the menstrual cycle on exercise responses at high altitude are Beidleman's [19] and the present one. We therefore feel that further studies will be needed to elucidate the explanation for the difference and to explore the possible mechanisms.
Both HVR and HCVR at rest have been reported to be increased in the luteal phase at SL [10, 11, 13, 14] . Possibly, the existence of additional ventilatory stimuli at moderate altitude exaggerates the modulating effects of the menstrual cycle on the respiratory response to exercise. We suggest that at moderate altitude, even in the absence of a difference in aerobic work capacity (VO 2 peak ) between the luteal and follicular phases, there may be reduced ventilatory efficiency (VE/VO 2 ) in the luteal phase. These results lead us to the practical suggestion that elite female athletes and their coaches should be careful in devising their practice schedule in the luteal phase to take account of the hyperventilation and reduction in ventilatory efficiency that may occur in this phase during altitude training. However, we should point out that a limitation of the present study was that it dealt with the effects of "acute" altitude exposure on modulations associated with the menstrual cycle. This should be borne in mind before applying these results to "chronic" exposure to altitude (e.g., altitude training for runners and swimmers).
In conclusion, VE and VO 2 (both at rest and during exercise) showed no significant elevation associated with the luteal phase, either at SL or at moderate altitude (3,000 m). However, VE/VO 2 (both at rest and during peak exercise) was significantly greater in the luteal phase than in the follicular phase, but only during HH. These results suggest that the menstrual cycle-induced modulation of the ventilatory response to exercise may be altered under acute HH conditions.
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